Immunexpress to Present SeptiCyte® RAPID Comparative Data Against Lactate and Procalcitonin for Diagnosing Sepsis at IDWeek 2021

Immunexpress.com

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced a presentation demonstrating comparative data of SeptiCyte® RAPID, lactate, and procalcitonin in differentiating sepsis from infection negative systemic inflammation at IDWeek 2021, taking place virtually on Sept. 29 – Oct. 3, 2021.   Details of the presentations are as…

Read More

10News Brisbane

SeptiCyte RAPID is highlighted in this 10News First Brisbane interview. The country’s largest pediatric sepsis study at the Queensland Children’s Hospital is working on finding simple diagnostic blood tests for the 5,000 Australians a year and robs others of their limbs.

Read More